N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses
- PMID: 17239689
- DOI: 10.1016/j.ahj.2006.09.014
N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses
Abstract
Background: The use of N-acetylcysteine for the prevention of contrast-induced nephropathy has been the subject of numerous clinical trials and meta-analyses. We sought to examine the possibility of a publication bias and whether meta-analyses have magnified any potential publication bias.
Methods: We performed a Medline search and a manual search to identify published manuscripts. We also manually searched contemporaneous major cardiology scientific meetings to identify abstracts. We included only randomized controlled clinical trials. We pooled the results of abstracts and manuscripts separately and combined, calculating an odds ratio (OR). We analyzed meta-analyses according to the proportions of manuscripts and abstracts that they included and compared their calculated ORs to the OR of all available contemporaneous data. Our analysis spanned the time from the publication of the first manuscript on this topic through June 2006.
Results: Throughout the study period, the published manuscripts presented a treatment-effect estimate that was more optimistic than that found in unpublished abstracts. There was a temporal trend in that the estimate of treatment effect was greatest with early publications, which diminished as additional data became available. The profile of the journal (as assessed by impact factor) in which a manuscript was published was not related to the quality of the manuscript. However, studies reaching a positive conclusion were published in journals with higher impact factors compared with studies reaching negative conclusions. Meta-analyses included a substantially greater proportion of published manuscripts versus unpublished abstracts and provided more optimistic assessments of treatment effect than would have been derived had all available data been assessed.
Conclusions: There was a significant publication bias that persisted throughout the life cycle of this clinical question. The bias was further amplified by meta-analyses.
Comment in
-
The evolution of evidence: cautionary notes for the clinician and the meta-analyst.Am Heart J. 2007 Feb;153(2):156-8. doi: 10.1016/j.ahj.2006.10.028. Am Heart J. 2007. PMID: 17239671 No abstract available.
Similar articles
-
Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.Am J Med. 2004 Dec 15;117(12):938-47. doi: 10.1016/j.amjmed.2004.06.046. Am J Med. 2004. PMID: 15629733
-
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.Am Heart J. 2006 Jan;151(1):140-5. doi: 10.1016/j.ahj.2005.01.055. Am Heart J. 2006. PMID: 16368307
-
[Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].Zentralbl Chir. 2007 Jun;132(3):227-31. doi: 10.1055/s-2007-960756. Zentralbl Chir. 2007. PMID: 17610195 German.
-
Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.BMJ. 2006 Jan 28;332(7535):202-9. doi: 10.1136/bmj.38693.516782.7C. Epub 2006 Jan 16. BMJ. 2006. PMID: 16415336 Free PMC article. Review.
-
N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?Pharmacotherapy. 2005 Aug;25(8):1095-103. doi: 10.1592/phco.2005.25.8.1095. Pharmacotherapy. 2005. PMID: 16207100 Review.
Cited by
-
Contrast-induced acute kidney injury: short- and long-term implications.Semin Nephrol. 2011 May;31(3):300-9. doi: 10.1016/j.semnephrol.2011.05.009. Semin Nephrol. 2011. PMID: 21784279 Free PMC article. Review.
-
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.Clin J Am Soc Nephrol. 2013 Sep;8(9):1618-31. doi: 10.2215/CJN.11161012. Epub 2013 May 9. Clin J Am Soc Nephrol. 2013. PMID: 23660180 Free PMC article. Review.
-
Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice.Semin Intervent Radiol. 2010 Dec;27(4):348-59. doi: 10.1055/s-0030-1267860. Semin Intervent Radiol. 2010. PMID: 22550376 Free PMC article.
-
Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies).Ann Intensive Care. 2016 Dec;6(1):48. doi: 10.1186/s13613-016-0145-5. Epub 2016 May 27. Ann Intensive Care. 2016. PMID: 27230984 Free PMC article. Review.
-
Contrast-induced nephropathy: pathogenesis and prevention.Pediatr Nephrol. 2010 Feb;25(2):191-204. doi: 10.1007/s00467-009-1204-z. Epub 2009 May 15. Pediatr Nephrol. 2010. PMID: 19444480 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical